Stopped
NOTABLE-308 · Nimotuzumab Combined With Trifluridine/Tipiracil · Refractory Metastatic Colorectal Cancer
Withdrawn before enrolling
Biotech Pharmaceutical Co., Ltd.Phase 3 NCT06343116 Registry history of NCT06343116 on ClinicalTrials.gov (opens the registry)